Skip to main content
Medical Affairs
Our Company
Who We Are
Leadership
Focus Areas
Overview
Oncology
Immunology & Inflammation
Neurology
Pipeline
Ongoing Clinical Trials
Presentations & Publications
Patients & Care Partners
Expanded Access
Healthcare Professionals (Coming soon!)
Our Medicines
Join Us
Our Culture
Open Positions
News
Ono Pharma
ONO-4578
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (NCT06256328)
Oncology
Disease/Condition: Gastric Cancer
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer (NCT06948448)
Oncology
Disease/Condition: Colorectal Cancer
Back to top